Over-the-Counter (OTC) Pet Medication Market Report 2025

This Over-the-Counter (OTC) Pet Medication market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The over-the-counter (OTC) pet medication market size has grown strongly in recent years. It will grow from $8.73 billion in 2024 to $9.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increasing pet humanization trends, growing demand for convenience in pet care, expansion of retail channels, rising pet ownership rates, and evolving regulatory landscape.

The over-the-counter (OTC) pet medication market size is expected to see strong growth in the next few years. It will grow to $11.81 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to changing consumer attitudes toward pet health, increased awareness of preventive care, rising pet ownership, expanding product offerings, and demand for over-the-counter (OTC) pet medications. Major trends in the forecast period include integration of telemedicine in veterinary care, expansion of natural and organic product offerings, personalized pet health solutions, growth of e-commerce platforms, and increased focus on preventive care.

The increase in pet ownership is expected to drive the growth of the over-the-counter (OTC) pet medication market going forward. Pet ownership entails the legal and ethical duty of caring for and managing a domesticated animal as a companion. This rise in pet ownership stems from factors such as companionship, emotional support, higher living standards, urbanization, evolving family dynamics, and a growing awareness of the health and well-being benefits of pet ownership. Over-the-counter (OTC) pet medications offer pet owners convenient, affordable access to basic pet care solutions, providing quick remedies for common health issues. For example, in October 2023, the American Pet Products Association, a U.S.-based non-profit organization, reported that 86.9 million U.S. households owned a pet, accounting for 66% of all households in 2022. Additionally, in November 2022, Animal Medicines Australia, an Australian association representing animal health, noted that 69% of Australian households had pets in 2022. Thus, the rise in pet ownership is propelling the OTC pet medication market.

Leading companies in the over-the-counter (OTC) pet medication market are focused on innovation to maintain their market position. They are developing advanced products, such as the first monoclonal antibody treatments, to cater to pet health needs. Monoclonal antibodies are antibodies produced by identical immune cells derived from a single parent cell. For instance, Zoetis Inc., a prominent U.S.-based pharmaceutical company, introduced Bedinvetmab injection and Oclacitinib chewable tablets approved by the FDA (Food and Drug Administration). Oclacitinib chewable tablets received FDA approval for managing pruritus associated with allergic dermatitis and atopic dermatitis in dogs aged one year or older, marking a significant advancement in treating allergic itch and inflammation in U.S. canines.

In April 2023, PetMed Express Inc., an established U.S.-based online pharmacy company, acquired PetCareRx Inc. to strengthen its position in the online pet pharmacy market. This acquisition aims to expand product offerings, broaden the customer base, and enhance operational integration and customer relationships. PetCareRx Inc. is recognized for its comprehensive range of over-the-counter (OTC) pet medications and pet health and wellness solutions.

Major companies operating in the over-the-counter (OTC) pet medication market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Zoetis Inc., Boehringer Ingelheim IN, Elanco Animal Health Incorporated, VCA Animal Hospital Inc., Ceva Sante Animale S.A, Virbac S.A., PetIQ Holdings LLC, Vetoquinol S.A, Norbrook Laboratories Limited, Bimeda Inc., Med-Vet International Inc., Sergeant’s Pet Care Products Inc., Advecta, Zesty Paws, Durvet Inc., Pet King Brands, Animax Ltd., PetArmor.

North America was the largest region in the over-the-counter (OTC) pet medication market in 2024. The regions covered in the over-the-counter (OTC) pet medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the over-the-counter (OTC) pet medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Over-the-counter (OTC) pet medication refers to medicines and treatments for pets that are available without needing a prescription from a veterinarian. These medications can be bought in retail stores, online, or at pet supply outlets. They are designed for common pet health issues and preventive care, such as flea and tick treatments, dental products, supplements, and minor skin treatments.

The primary categories of over-the-counter (OTC) pet medication include flea and tick control, wormers and dewormers, dental care, nutritional supplements, skin and coat care, pain and allergy relief, and other medicines. Flea and tick control products are used to prevent and treat infestations of these parasites on pets. These products encompass topical treatments, collars, sprays, and oral medications that safeguard pets from fleas and ticks. These medications cater to various pets such as dogs, cats, birds, fishes, reptiles, and others, and are available in forms such as chews, treats, capsules, ointments, sprays, and more. They are distributed through different channels including drugstores, pet specialty shops, veterinary clinics, online retailers, and other outlets.

The over-the-counter (OTC) pet medication market research report is one of a series of new reports that provides over-the-counter (OTC) pet medication market statistics, including over-the-counter (OTC) pet medication industry global market size, regional shares, competitors with an over-the-counter (OTC) pet medication market share, detailed over-the-counter (OTC) pet medication market segments, market trends, and opportunities, and any further data you may need to thrive in the over-the-counter (OTC) pet medication industry. This over-the-counter (OTC) pet medication research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over-the-counter (OTC) pet medication market consists of sales of heartworm preventatives, digestive aids and probiotics, allergy relief medications, and worming medications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.